# Anti-viral Mechanisms of Defensins > **NIH NIH R01** · UNIVERSITY OF WASHINGTON · 2021 · $654,410 ## Abstract Project Summary The innate immune response is a critical component of host defense against infection. Alpha-defensins, one family of antimicrobial peptides, are an evolutionarily conserved class of innate immune effectors with well- described anti-bacterial activity; however, their role in viral immunity is less well understood. The potent neutralization of diverse viruses by alpha-defensins has been described in vitro and in cell culture. By focusing on human adenovirus and papillomavirus, we have identified a common mechanism whereby alpha-defensins bind to the viral capsid and alter uncoating during cell entry to block infection. Recently, we have found that viruses transmitted by the oral/fecal route (e.g., rotavirus and enteric adenovirus) are selectively resistant to the antiviral activity of alpha-defensins from their host species while remaining sensitive to non-host alpha- defensins. In some cases, the host alpha-defensins even increase or enhance the infection of these viruses, leading us to hypothesize that enteric viruses have evolved to either evade or hijack these host defense peptides to increase infection and transmission. To test this hypothesis, we will study the enhancement and neutralization of rotavirus by host and non-host alpha-defensins. Rotaviruses are important human pathogens and a deeper understanding of host factors that dictate their tropism is important for understanding transmission. These studies will combine biochemical and genetic approaches to identify alpha-defensin binding determinants on the viral capsids and to identify alpha-defensin properties that differentiate neutralizing and enhancing activities. We will also identify the mechanisms of rotavirus neutralization and enhancement. Finally, we will determine whether or not these mechanisms alter viral infection in vivo. To determine whether the antiviral mechanism that we have uncovered in our studies of adenovirus and HPV is general, we will also dissect the mechanism of parvovirus inhibition. Parvoviruses, particularly adeno- associated virus, are important viral vectors. In addition, there are well known (e.g., B19) and emerging (e.g., bocavirus) parvoviruses that are important human pathogens. These studies will be facilitated by high resolution structural studies of clinically relevant viral vectors. From these comparative studies of two disparate families of non-enveloped viruses in combination with our prior insights from human adenovirus and papillomavirus, we will gain a deeper understanding of the function of a critical component of the immune system that may be a common factor in the pathogenesis of many viruses. These studies may also aid in the development of alpha-defensins as therapeutics and inform vaccine design. ## Key facts - **NIH application ID:** 10142352 - **Project number:** 5R01AI104920-08 - **Recipient organization:** UNIVERSITY OF WASHINGTON - **Principal Investigator:** ROBERT MCKENNA - **Activity code:** R01 (R01, R21, SBIR, etc.) - **Funding institute:** NIH - **Fiscal year:** 2021 - **Award amount:** $654,410 - **Award type:** 5 - **Project period:** 2014-04-10 → 2024-04-30 ## Primary source NIH RePORTER: https://reporter.nih.gov/project-details/10142352 ## Citation > US National Institutes of Health, RePORTER application 10142352, Anti-viral Mechanisms of Defensins (5R01AI104920-08). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10142352. Licensed CC0. --- *[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*